Given that recent studies have demonstrated that serum NfL is correlated with clinical severity in SCA 3 patients15,16, in this study, the serum NfL level correlated well with various markers for clinical severity and the rate of disease progression in AD SCA. The gene discussed is NEFL; the disease is autosomal dominant cerebellar ataxia.